hi Donna,
glad you have found us and welcome to our forum.
the NHS fully funds Glivec as first line therapy for ph+ CML so if you decide to come back to the UK then you should have no problem getting access to Glivec. as you can see from David's post above both Dasatinib-Sprycel- and Nilotinib-Tasigna- are now very likely to be selected as topics for NICE appraisal.
although we are not sure yet of exactly when the appraisal will be, we are hopeful that it will be soon.
the message from NICE (national institute of health and clinical excellence) is very positive at this stage and we are hoping is a good indicator that both the newer drugs will be available and fully funded by the NHS for Glivec resistant/intolerant patients at some point next year.
as Russ says in his post above, there are several centres of excellence for CML here in the UK. Kings or Hammersmith would probably be the most relevant to you should you move back to the south.
very best wishes,
Sandy